These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28304291)

  • 1. Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease.
    Lutski M; Weinstein G; Goldbourt U; Tanne D
    J Alzheimers Dis; 2017; 57(2):633-643. PubMed ID: 28304291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein is related to future cognitive impairment and decline in elderly individuals with cardiovascular disease.
    Weinstein G; Lutski M; Goldbourt U; Tanne D
    Arch Gerontol Geriatr; 2017; 69():31-37. PubMed ID: 27886564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study.
    Hooshmand B; Rusanen M; Ngandu T; Leiviskä J; Sindi S; von Arnim CAF; Falkai P; Soininen H; Tuomilehto J; Kivipelto M
    Am J Med; 2019 Mar; 132(3):367-373. PubMed ID: 30502316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes.
    Tenenbaum H; Behar S; Boyko V; Adler Y; Fisman EZ; Tanne D; Lapidot M; Schwammenthal E; Feinberg M; Matas Z; Motro M; Tenenbaum A
    Atherosclerosis; 2007 Sep; 194(1):265-71. PubMed ID: 16970952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Health and Cognitive Decline 2 Decades Later in Men with Preexisting Coronary Artery Disease.
    Lutski M; Weinstein G; Goldbourt U; Tanne D
    Am J Cardiol; 2018 Feb; 121(4):410-415. PubMed ID: 29273206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Lipids, Apolipoproteins, and Subsequent Cognitive Decline in Men with Coronary Heart Disease.
    Lutski M; Weinstein G; Goldbourt U; Tanne D
    J Alzheimers Dis; 2019; 67(3):827-837. PubMed ID: 30664505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between cognitive performance and insulin resistance in non-diabetic patients with mild cognitive impairment.
    Kim TE; Lee DH; Kim YJ; Mok JO; Kim CH; Park JH; Lee TK; Yoo K; Jeong Y; Lee Y; Park SA
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):551-7. PubMed ID: 25060738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and cognitive test performance in elderly adults: National health and nutrition examination survey (NHANES).
    Sherzai AZ; Shaheen M; Yu JJ; Talbot K; Sherzai D
    J Neurol Sci; 2018 May; 388():97-102. PubMed ID: 29627040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample.
    Ekblad LL; Rinne JO; Puukka P; Laine H; Ahtiluoto S; Sulkava R; Viitanen M; Jula A
    Diabetes Care; 2017 Jun; 40(6):751-758. PubMed ID: 28381479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance is associated with poorer verbal fluency performance in women.
    Ekblad LL; Rinne JO; Puukka PJ; Laine HK; Ahtiluoto SE; Sulkava RO; Viitanen MH; Jula AM
    Diabetologia; 2015 Nov; 58(11):2545-53. PubMed ID: 26276262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate.
    Tenenbaum A; Fisman EZ; Boyko V; Benderly M; Tanne D; Haim M; Matas Z; Motro M; Behar S
    Arch Intern Med; 2006 Apr; 166(7):737-41. PubMed ID: 16606809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Cerebral Hemodynamics and Cognitive Performance in Patients with Atherothrombotic Disease.
    Haratz S; Weinstein G; Molshazki N; Beeri MS; Ravona-Springer R; Marzeliak O; Goldbourt U; Tanne D
    J Alzheimers Dis; 2015; 46(1):137-44. PubMed ID: 25720410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.
    Sullivan MD; Katon WJ; Lovato LC; Miller ME; Murray AM; Horowitz KR; Bryan RN; Gerstein HC; Marcovina S; Akpunonu BE; Johnson J; Yale JF; Williamson J; Launer LJ
    JAMA Psychiatry; 2013 Oct; 70(10):1041-7. PubMed ID: 23945905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.
    Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
    Atherosclerosis; 2011 Dec; 219(2):839-45. PubMed ID: 21959256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical frailty and cognitive function among men with cardiovascular disease.
    Weinstein G; Lutski M; Goldbourt U; Tanne D
    Arch Gerontol Geriatr; 2018; 78():1-6. PubMed ID: 29864738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study.
    Cholerton B; Omidpanah A; Verney SP; Nelson LA; Baker LD; Suchy-Dicey A; Longstreth WT; Howard BV; Henderson JA; Montine TJ; Buchwald D
    Int J Geriatr Psychiatry; 2019 Jul; 34(7):1050-1057. PubMed ID: 30924200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study.
    Gómez-Martínez C; Babio N; Júlvez J; Becerra-Tomás N; Martínez-González MÁ; Corella D; Castañer O; Romaguera D; Vioque J; Alonso-Gómez ÁM; Wärnberg J; Martínez JA; Serra-Majem L; Estruch R; Tinahones FJ; Lapetra J; Pintó X; Tur JA; López-Miranda J; Bueno-Cavanillas A; Gaforio JJ; Matía-Martín P; Daimiel L; Martín-Sánchez V; Vidal J; Vázquez C; Ros E; Dalsgaard S; Sayón-Orea C; Sorlí JV; de la Torre R; Abete I; Tojal-Sierra L; Barón-López FJ; Fernández-Brufal N; Konieczna J; García-Ríos A; Sacanella E; Bernal-López MR; Santos-Lozano JM; Razquin C; Alvarez-Sala A; Goday A; Zulet MA; Vaquero-Luna J; Diez-Espino J; Cuenca-Royo A; Fernández-Aranda F; Bulló M; Salas-Salvadó J
    Front Endocrinol (Lausanne); 2021; 12():754347. PubMed ID: 34777250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mid-life insulin resistance and type 2 diabetes on older-age cognitive state: the explanatory role of early-life advantage.
    James SN; Wong A; Tillin T; Hardy R; Chaturvedi N; Richards M
    Diabetologia; 2019 Oct; 62(10):1891-1900. PubMed ID: 31359084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.